Expression and glycoengineering of functionally active heteromultimeric IgM in plants. - Wikidata - awgldk - TriplyDB

Expression and glycoengineering of functionally active heteromultimeric IgM in plants.

Expression and glycoengineering of functionally active heteromultimeric IgM in plants.

http://www.wikidata.org/entity/Q30412932

about

Recent Advances in Clinical Glycoproteomics of Immunoglobulins (Igs)Production of monoclonal antibodies in plants for cancer immunotherapy Expression of recombinant vaccines and antibodies in plants Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies Engineering of complex protein sialylation in plants.Designed IgM from glycoengineering.Exploring Site-Specific N-Glycosylation of HEK293 and Plant-Produced Human IgA Isotypes.Intramolecular N-glycan/polypeptide interactions observed at multiple N-glycan remodeling steps through [(13)C,(15)N]-N-acetylglucosamine labeling of immunoglobulin G1.A Microarray-Matrix-assisted Laser Desorption/Ionization-Mass Spectrometry Approach for Site-specific Protein N-glycosylation Analysis, as Demonstrated for Human Serum Immunoglobulin M (IgM).Glycan-independent binding and internalization of human IgM to FCMR, its cognate cellular receptor.Using glyco-engineering to produce therapeutic proteins.Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment.Transient Glyco-Engineering to Produce Recombinant IgA1 with Defined N- and O-Glycans in Plants Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity.Introduction of germline residues improves the stability of anti-HIV mAb 2G12-IgM Reduced paucimannosidic N-glycan formation by suppression of a specific β-hexosaminidase from Nicotiana benthamiana.Techno-economic analysis of a transient plant-based platform for monoclonal antibody production.Site-Directed Glycosylation of Peptide/Protein with Homogeneous O-Linked Eukaryotic N-Glycans.An oligosaccharyltransferase from Leishmania major increases the N-glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana.Site-Specific N-Glycosylation of Recombinant Pentameric and Hexameric Human IgM.Proteolytic and N-glycan processing of human α1-antitrypsin expressed in Nicotiana benthamiana

P2860

Q26752274-26AC104E-A3BA-4897-8781-899E190E5AC4 Q26778423-4971C7E6-B207-46F9-9BE3-19831DCCF34E Q27027725-A66C559A-E9AB-4717-9057-08D0F32D512F Q28069362-837D0E01-6661-43DD-9A06-6004309524B8 Q30313981-B615F402-6D44-43FF-94C5-02B0D0B42799 Q33674739-79F5A782-570B-45AE-B8F9-E1147F44FD53 Q33891585-4D25BCC7-F3A4-4A6F-A117-E72974D9B3F9 Q34999126-8E8AAF49-56B5-4EA6-99F4-127E96865797 Q35584921-73C847C6-41FA-45DA-A251-95296EE9355B Q37661103-1CC75F3D-C17E-4CAE-A30C-FBCE310D76B9 Q38547311-F366F682-5513-4E62-8660-806A12E20196 Q38955887-7BA63062-81FC-40F1-95F9-05BB35545957 Q40011916-35ABF491-32CF-4357-9A42-650A2A194E98 Q40078229-CE2D294C-2B26-418B-887D-D5243B3FB978 Q41273804-88CB9A34-95F4-4897-B211-93CF2402E07A Q42105653-23567936-AF82-4396-AC8B-F7DFB5F87C85 Q42373048-DF170DF8-D250-43FB-B275-38D4E2C02B29 Q49114623-A3C64F98-67A2-4BA7-ADC3-F81A52C8899C Q52373100-5AE57AC1-05FD-4D51-A2F3-5D1719977660 Q53163993-9213F0E6-46E4-434F-831B-27E4B9460814 Q56974439-D12AAD4D-198A-485E-8632-FBFEBB0E45B9

P2860

Expression and glycoengineering of functionally active heteromultimeric IgM in plants.

http://www.wikidata.org/entity/Q30412932

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Expression and glycoengineering of functionally active heteromultimeric IgM in plants.

@ast

Expression and glycoengineering of functionally active heteromultimeric IgM in plants.

@en

type

label

Expression and glycoengineering of functionally active heteromultimeric IgM in plants.

@ast

Expression and glycoengineering of functionally active heteromultimeric IgM in plants.

@en

prefLabel

Expression and glycoengineering of functionally active heteromultimeric IgM in plants.

@ast

Expression and glycoengineering of functionally active heteromultimeric IgM in plants.

@en

P1433

Q30412932-E3EBD541-33C6-4929-AD51-D99FCD32FFE3

P1476

Q30412932-73C46450-24DE-4FE5-B64F-3D96BD205183

P2093

Q30412932-3568A605-48DF-4CDC-A216-0525E867F228

Q30412932-50C47276-E8B5-48E9-AB1C-2597D2175274

Q30412932-6BFC4203-25BB-4E82-986A-B909496AD2F4

Q30412932-774ED8AC-1C44-4D26-A945-32DC2417081D

Q30412932-9C094D8D-9151-4DCE-83DC-DB01BD6DA06D

Q30412932-E758F8FA-87BB-4DE9-B551-9B4CA51301B0

P2860

Q30412932-006DDCC1-CC9D-435E-AE66-86D5462918DA

Q30412932-089ECFCF-F837-4299-A958-6997C9E48668

Q30412932-182EB5A1-D57E-4906-88D9-C5FBB2999461

Q30412932-18369D91-93A4-4764-AD25-E4AB82CC27E7

Q30412932-2A840E98-7F01-4C95-A854-46EDC961D421

Q30412932-2C57CB46-EA4B-4E28-A8BA-B6B457419A64

Q30412932-3ACB358C-C3B7-410C-AEE4-2B7B47259F95

Q30412932-463D79F2-4500-49E8-99EF-A32B05E248BD

Q30412932-47D989DE-06C3-4B45-BFF5-CF847F395721

Q30412932-49546702-0C1E-44A3-B517-E144F1BB8575

P304

Q30412932-65B0557E-3E1C-47BE-9387-EE7BBE16C44F

P31

Q30412932-3935E3D9-758A-4FBE-921B-A6B5237591B2

P356

Q30412932-80BBBB56-C14C-41FB-8C32-A5094890F088

P407

Q30412932-57706954-47D2-4EC7-976F-C4C6534CA21E

P433

Q30412932-41E4CC73-B780-401D-B40C-C25969B1E592

P478

Q30412932-13133E11-3931-4BCD-AF71-3D5F96AD5D71

P50

Q30412932-279A0E8D-C38B-4A85-AC63-69CDE9621144

Q30412932-40581C6B-9E02-44B0-B186-63AC30F4A325

Q30412932-54AC74F7-35F9-4167-A84E-CDCEE2C941F4

Q30412932-635FA706-D237-43A4-9F85-62277B25B511

P577

Q30412932-A637D422-FF17-427C-80EC-60BDD40E6B5F

P5875

Q30412932-E03B25C6-CDF3-4D82-9F29-6D31630D5936

P698

Q30412932-75AEFB2A-BE07-40BC-B60B-7FE698580E5E

P932

Q30412932-CFA81E11-4454-417E-9919-21602537AC09

P356

PNAS.1320544111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Expression and glycoengineering of functionally active heteromultimeric IgM in plants.

@en

P2093

Andreas Loos

http://www.w3.org/2001/XMLSchema#string

Clemens Gruber

http://www.w3.org/2001/XMLSchema#string

Frank Hensel

http://www.w3.org/2001/XMLSchema#string

Gerhard Stadlmayr

http://www.w3.org/2001/XMLSchema#string

Melanie Grandits

http://www.w3.org/2001/XMLSchema#string

Ulrich Mehofer

http://www.w3.org/2001/XMLSchema#string

P2860

Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis

The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling

Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides

Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors.

The human IgM pentamer is a mushroom-shaped molecule with a flexural bias.

Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin.

Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.

IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1

Natural IgM antibodies: the orphaned molecules in immune surveillance.

The impact of glycosylation on the biological function and structure of human immunoglobulins.

P304

6263-6268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1320544111

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Chris Oostenbrink

Paul G. Furtmüller

Herta Steinkellner

Friedrich Altmann

P577

2014-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261409806

http://www.w3.org/2001/XMLSchema#string

P698

24706782

http://www.w3.org/2001/XMLSchema#string

P932

4035941

http://www.w3.org/2001/XMLSchema#string